BE755071A - Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone - Google Patents

Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone

Info

Publication number
BE755071A
BE755071A BE755071DA BE755071A BE 755071 A BE755071 A BE 755071A BE 755071D A BE755071D A BE 755071DA BE 755071 A BE755071 A BE 755071A
Authority
BE
Belgium
Prior art keywords
terbutylamino
naphthalenone
propoxy
resolving
dihydro
Prior art date
Application number
Other languages
English (en)
French (fr)
Inventor
J Shavel
C F Schwender
Original Assignee
Warner Lambert Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE755071A publication Critical patent/BE755071A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BE755071D 1969-09-17 Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone BE755071A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US85924469A 1969-09-17 1969-09-17

Publications (1)

Publication Number Publication Date
BE755071A true BE755071A (fr) 1971-02-22

Family

ID=25330421

Family Applications (1)

Application Number Title Priority Date Filing Date
BE755071D BE755071A (fr) 1969-09-17 Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone

Country Status (13)

Country Link
US (1) US3649691A (OSRAM)
JP (1) JPS494218B1 (OSRAM)
BE (1) BE755071A (OSRAM)
BR (1) BR7022215D0 (OSRAM)
CH (1) CH540882A (OSRAM)
DE (1) DE2046043C3 (OSRAM)
DK (1) DK139356B (OSRAM)
ES (1) ES383643A1 (OSRAM)
FR (1) FR2068537B1 (OSRAM)
GB (1) GB1264775A (OSRAM)
NL (1) NL7013663A (OSRAM)
NO (1) NO135141C (OSRAM)
ZA (1) ZA704981B (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2130393C3 (de) * 1970-06-22 1981-02-26 E.R. Squibb & Sons Inc., New York, N.Y. (V.St.A.) 6,7-Dihydroxy -5,6,7,8-tetrahydronaphthyloxyaminopropanole und ihre Salze mit Säuren sowie ihre Verwendung bei der Bekämpfung von Herzerkrankungen
GB1464950A (en) * 1973-05-03 1977-02-16 Squibb & Sons Inc Naphthalene derivatives
GB1458392A (en) * 1973-11-09 1976-12-15 Ici Ltd Optically-active 1-aryloxy-2,3-epoxypropane derivatives
CH621330A5 (OSRAM) * 1976-05-14 1981-01-30 Sandoz Ag
JPS5334024U (OSRAM) * 1976-08-31 1978-03-25
IT1113029B (it) * 1979-03-01 1986-01-20 Simes Processo per la separazione dei due isomeri ottici del moprololo e composizioni farmaceutiche dell'antipodo levogiro
US5266599A (en) * 1989-02-20 1993-11-30 Jouveinal S.A. Use of (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine to increase gastric discharge in a subject
US5245080A (en) * 1989-02-20 1993-09-14 Jouveinal Sa (+)-1-[(3,4,5-trimethoxy)-benzyloxymethyl]-1-phenyl-N,N-dimethyl-N-propylamine, process for preparing it and its therapeutical use
ES2065278B1 (es) * 1993-06-24 1995-09-01 Medichem Sa Procedimiento de obtencion enantioselectivo del levobunolol.
KR20110117731A (ko) * 2003-05-30 2011-10-27 랜박시 래보러터리스 리미티드 치환된 피롤 유도체와 ｈｍｇ―ｃｏ 억제제로서의 이의 용도
JP2009514851A (ja) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
TW200811101A (en) * 2006-07-14 2008-03-01 Ranbaxy Lab Ltd Polymorphic forms of an HMG-CoA reductase inhibitor and uses thereof
WO2008112287A1 (en) * 2007-03-12 2008-09-18 Nektar Therapeutics Oligomer-beta blocker conjugates

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2974148A (en) * 1959-03-30 1961-03-07 Smith Kline French Lab Anorexigenic preparation and method of curbing the appetite
US3641152A (en) * 1968-09-23 1972-02-08 Warner Lambert Pharmaceutical 3 4-dihydronaphthalenoneoxy-2-hydroxy-propylamines

Also Published As

Publication number Publication date
DE2046043A1 (de) 1971-03-25
US3649691A (en) 1972-03-14
NO135141C (OSRAM) 1977-02-16
DE2046043C3 (de) 1978-12-14
FR2068537A1 (OSRAM) 1971-08-27
NL7013663A (OSRAM) 1971-03-19
FR2068537B1 (OSRAM) 1974-02-01
GB1264775A (OSRAM) 1972-02-23
JPS494218B1 (OSRAM) 1974-01-31
CH540882A (de) 1973-08-31
BR7022215D0 (pt) 1973-04-26
DE2046043B2 (de) 1978-03-30
ES383643A1 (es) 1976-06-01
ZA704981B (en) 1971-07-28
NO135141B (OSRAM) 1976-11-08
DK139356B (da) 1979-02-05
DK139356C (OSRAM) 1979-08-20

Similar Documents

Publication Publication Date Title
BE755071A (fr) Procede de resolution de la dl-5-/3-(terbutylamino)-2- hydroxy-propoxy/-3,4-dihydro-1(2h) naphtalenone
BG22829A3 (bg) Метод за получаване на аминодибензо(в,d)пирани
BE757999A (fr) Procede de preparation de bromonitro-alcools.
BG21208A3 (bg) Метод за получаване на 1- алилокси-2- хидрокси -3- алкинилами- нопропани
NO138304C (no) Opploesningsanalysator.
BG27080A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4- оксипиперидин
BE765185A (fr) Procede de fonderie
SE411617B (sv) Slirsystem for dubbla bromskretsar
BE799963A (fr) Procede de preparation de poly-(halogenures de vinyle),
BG27081A3 (bg) Метод за получаване на 2,2,6,6-тетраметил-4- оксипиперидин
CH550152A (fr) Procede de preparation de nouvelles iodomethylsulfones.
NO137817C (no) Apparat for bygging av skip.
BE821895A (fr) Procede de preparation de 4-amino-diphenylamine
CH553785A (fr) Procede de preparation de nouvelles dibenzoazepines.
BE837825A (fr) Procede pour extraire de longs tubes
BG27747A3 (bg) Метод за получаване на субституирани епоксиетани
NL158545B (nl) Werkwijze ter bereiding van een antibioticum.
CH551937A (fr) Procede de preparation de saligenol.
CH548964A (fr) Procede de preparation de tetrahydro-cyclopropa (b)naphtalenes.
BE764420A (fr) Procede de preparation de sulfochlorures fluores
SU570462A1 (ru) Устройство дл холодной ломки проката
BE808664A (fr) Procede de conversion
NO138676C (no) Fremgangsmaate til avstandsmaaling.
BE803871A (fr) Procede de mise en boite
BG17813A3 (bg) Метод за получаване на холинестери на ацилпропан- диол-/1,3/-фосфорна киселина